Cellyan Biotechnology (HKPD)

Its activities are organised around two main business lines. The Supply Chain Services division, conducted through the Hong Kong subsidiary Joint Cross Border, provides third-party supply chain services for OTC pharmaceutical cross-border e-commerce. This includes support functions that help brands, sellers, or platform participants manage the movement of healthcare products through compliant and efficient commercial channels. The division’s role is to support market access and fulfilment in a sector where logistics, documentation, sourcing, and channel relationships are important.

The company also operates a Procurement and Distribution division through V-Alliance, another Hong Kong subsidiary. This business is involved in sourcing and distributing OTC pharmaceutical products, serving demand from customers seeking access to recognised healthcare goods across borders. The company’s focus on non-prescription pharmaceuticals places it in a market influenced by consumer health trends, online retail adoption, regulatory requirements, and demand for trusted branded products.

For investors, Cellyan Biotechnology is best understood as a specialised supply chain and distribution company rather than a conventional drug developer. Its performance depends on the scale and reliability of cross-border OTC pharmaceutical commerce, relationships with suppliers and customers, regulatory conditions in Hong Kong and Mainland China, and its ability to compete in a market where fulfilment quality and product authenticity are central to customer confidence.